TP53 and lung cancer: In addition, VRK1 expression correlates positively with several proliferation markers in head-and-neck squamous cell cancers and lung carcinomas [15, 16], and VRK1 levels tend to be elevated in lung cancer tissues in which p53 is mutated [16].